Consenting for this protocol will be a two-step process. The first consent (named Clinical Management Consent) will allow Investigators to assess the acute needs and provide appropriate clinical care. The second consent (named Screening and Research Consent) will allow Investigators to conduct screening and research data collection and analysis.The substudy will have its own consent, the Addictions Neuroclinical Assessment (ANA) consent.